Cambridge Nucleomics
PrivateLast Round
Pre Seed
Mar 6, 2025
Est. Valuation
$2.67M
Total Funding Raised
$923,000
Company Overview
Cambridge Nucleomics is a biotechnology company that is developing a platform for rapid, highly multiplexed nucleic acid biomarker detection for applications in diagnostics and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cambridge Nucleomics Comps
Public and private peers based on sector, stage, and business model.
Cambridge Nucleomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 6, 2025 | ||||
| Grant | Jan 25, 2024 | ||||
| Accelerator | Apr 4, 2023 |
Cambridge Nucleomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cambridge Angels | Pre Seed |
| Berkeley SkyDeck | Accelerator |
| Trinity College Cambridge | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 6, 2025
$710K round led by Cambridge Angels
- Jan 25, 2024
$13K grant received from The Bradfield Centre and Trinity College Cambridge.
Cambridge Nucleomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cambridge Nucleomics's valuation, stock price, and market status.
